News-Papers
Testimonial
Video Gallery
Octreotide: an active agent in epithelial ovarian carcinoma?
Published on Monday, 23 November 2015
See also Somatostatin in oncology, the overlooked evidences.
Search
Follow us...
Latest
- Melatonin induces apoptosis in human neuroblastoma cancer cells
- Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
- Melatonin inhibits growth of B16 melanoma in C57BL/6 mice
- Somatostatin in oncology, the overlooked evidences
- Complete objective response of neuroblastoma to biological treatment
- Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status
- Radio-protective effects of melatonin against irradiation-induced oxidative damage in rat peripheral blood
- Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
- Melatonin, mitochondria, and the cancer cell
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells
- Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibroblasts
- Melatonin: reducing the toxicity and increasing the efficacy of drugs
- Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro
- Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
- Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
- Molecular aspects of melatonin (MLT)-mediated therapeutic effects
- Molecular mechanisms of melatonin anticancer effects
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Bibliography
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer